A rising number of studies have recently focused on the role of CDK7 in cancer, but we observed limited data on the role of CDK7 inhibitors in combination with chemotherapy, particularly in pancreatic cancer. The gene discussed is CDK7; the disease is familial pancreatic carcinoma.